Amlo Biosciences Limited
11004534
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 05/12/2017
BUSINESS DEVELOPMENT MANAGER
BRITISH · UNITED KINGDOM · Age 57
Also on 1 other board
director · Since 24/11/2020
CONSULTANT
BRITISH · ENGLAND · Age 81
Also on 7 other boards
director · Since 01/03/2021
CONSULTANT
BRITISH · UNITED KINGDOM · Age 63
Also on 1 other board
Persons with Significant Control
Former PSCs
Dr Paul John Edwards
Ceased 03/03/2018
CompanyRankvs 40630+ SIC 71200 peers40
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/11/2024
Net Worth
-£621k
Balance sheet strength
Cash
£537k
Cash in the bank
Net Current Assets
-£1.0M
Working capital
Current Assets
£852k
Current Liabilities
£1.9M
Fixed Assets
£563k
Debtors
£315k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.45 | -£622k |
| 2023 | 3.73 | — |
| 2022 | 12.26 | — |
| 2021 | 9.30 | — |
| 2020 | 17.19 | — |
| 2019 | 10.69 | — |
| 2018 | 16.19 | — |
Derived from filed accounts. Not audited figures.